Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2990859 | 0.73 | RET (0.41) | — | |
| SCHEMBL1128608 | 0.72 | — | — | |
| SCHEMBL9814192 | 0.71 | HSD11B1 (0.35) | — | |
| SCHEMBL10784662 | 0.71 | ALDH1A1 (0.43) | ALDH1A1NPSR1 | |
| SCHEMBL1069856 | 0.71 | — | — | |
| SCHEMBL14721175 | 0.70 | ALDH1A1 (0.45) | ALDH1A1NPSR1 | |
| SCHEMBL23817169 | 0.69 | ALDH1A1 (0.47) | ALDH1A1NPSR1 | |
| SCHEMBL18503901 | 0.69 | ALDH1A1 (0.47) | ALDH1A1NPSR1 | |
| SCHEMBL6142600 | 0.69 | ALDH1A1 (0.47) | ALDH1A1NPSR1 | |
| SCHEMBL2989495 | 0.68 | ALDH1A1 (0.36) | ALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6828283-B2 | Traction fluids in toroidal continuously variable transmission (T-CVT) systems | GENBERAL MOTORS CORPORATION | 2004-12-07 | — | — | US | disclosed |
| US-20040152931-A1 | Traction fluid with alkane bridged dimer | GM Global Technology Operations LLC | 2004-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152931-A1 | Traction fluid with alkane bridged dimer | CCL11, CCL2, TLN1 | ALDH1A1 2451/4885NPSR1 2845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.